References

Agarwal-Antal, N., Bowen, G.M., & Gerwels, J.W. (2002). Histologic evaluation of lentigo maligna with permanent sections: Implications regarding current guidelines. Journal of the American Academy of Dermatology, 47(5), 743-748.
Ahmed, I., & Berth-Jones, J. (2000). Imiquimod: A novel treatment for lentigo maligna. British Journal of Dermatology, 143(4), 843-845.
Arndt, K.A. (1986). New pigmented macule appearing 4 years after argon laser treatment of lentigo maligna. Journal of the American Academy of Dermatology, 14(6), 1092.
Chapman, M.S., Spencer, S.K., & Brennick, J.B. (2003). Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. Archives of Dermatology, 139(7), 943-944.
Cohen, L.M., McCall, M.W., Hodge, S.J., Freedman, J.D., Callen, J.P., & Zax, R.H. (1994). Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer, 73(12), 2964-2970.
Cohen, L.M., McCall, M.W., & Zax, R.H. (1998). Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: A follow-up study. Dermatologic Surgery, 24(6), 673-677.
Coleman, W.P., III, Davis, R.S., Reed, R.J., & Krementz, E.T. (1980). Treatment of lentigo maligna and lentigo maligna melanoma. The Journal of Dermatologic Surgery and Oncology, 6(6), 476-479.
Cornejo, P., Vanaclocha, F., Polimon, I., & Del Rio, R. (2000). Intralesional interferon treatment of lentigo maligna. Archives of Dermatology, 136(3), 428-430.
Davis, J., Pack, G.T., & Higgins, G.K. (1967). Melanotic freckle of Hutchinson. American Journal of Surgery, 113(4), 457-463.
Donnellan, M.J., Seemayer, T., Huvos, A.G., Mike, V., & Strong, E.W. (1972). Clinicopathologic study of cutaneous melanoma of the head and neck. American Journal of Surgery, 124(4), 450-455.
Epstein, E. (2003). Extensive lentigo maligna clearing with topical imiquimod. Archives of Dermatology, 139(7), 944-945.
Farshad, A., Burg, G., Panizzon, R., & Dummer, R. (2002). A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. British Journal of Dermatology, 146(6), 1042-1046.
Fisher, G.H., & Lang, P.G. (2003). Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Archives of Dermatology, 139(7), 945- 947.
Huvos, A.G., Mike, V., Donnellan, M.J., Seemayer, T., & Strong, E.W. (1973). Prognostic factors in cutaneous melanoma of the head and neck. American Journal of Pathology, 71(1), 33-48.
Jackson, R., Williamson, G.S., & Beattie, W.G. (1966). Lentigo maligna and malignant melanoma. Canadian Medical Association Journal, 95(17), 846-851.
Koh, H.K., Michalik, E., Sober, A.J., Lew, R.A., Day, C.L., Clark, W., et al. (1984). Lentigo maligna melanoma has no better prognosis than other types of melanoma. Journal of Clinical Oncology, 2(9), 994-1001.
Kopera, D. (1995). Treatment of lentigo maligna with the carbon dioxide laser. Archives of Dermatology, 131(6), 735-736.
Kuflik, E.G., & Gage, A.A. (1994). Cryosurgery for lentigo maligna. Journal of the American Academy of Dermatology, 31(1), 75-78.
Langford, F.P., Fisher, S.R., Molter, D.W., & Seigler, H.F. (1993). Lentigo maligna melanoma of the head and neck. Laryngoscope, 103(5), 520-524.
Lee, P.K., Rosenberg, C.N., Tsao, H., & Sober, A.J. (1998). Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: Report of two cases. Journal of the American Academy of Dermatology, 38(2 Pt 2), 314-317.
Little, J.H., Holt, J., & Davis, N. (1980). Changing epidemiology of malignant melanoma in Queensland. The Medical Journal of Australia, 1(2), 66-69.
Litwin, M.S., Krementz, E.T., Mansell, P.W., & Reed, R.J. (1975). Topical chemotherapy of lentigo maligna with 5-fluorouracil. Cancer, 35(3), 721-733.
McGovern, V.J. (1970). The classification of melanoma and its relationship with prognosis. Pathology, 2(2), 85-98.
McGovern, V.J., Shaw, H.M., Milton, G.W., & Farago, G.A. (1980). Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology, 4(3), 235-242.
Menaker, G.M., Chiang, J.K., Tabila, B., & Moy, R.L. (2001). Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma. Journal of the American Academy of Dermatology, 44(5), 833-836.
Nazzaro-Porro, M., Passi, S., Zina, G., & Breathnach, A.S. (1989). Ten years' experience of treating lentigo maligna with topical azelaic acid. Acta Dermato-Venereologica Supplementum (Stockholm), 143, 49-57.
NIH Consensus Development Panel on Early Melanoma for the NIH Consensus Conference. (1992). Diagnosis and treatment of early melanoma. The Journal of the American Medical Association, 268(10), 1314- 1319.
Orten, S.S., Waner, M., Dinehart, S.M., Bardales, R.H., & Flock, S.T. (1999). Q-switched neodymium:yttrium- aluminum-garnet laser treatment of lentigo maligna. Otolaryngology and Head and Neck Surgery, 120(3), 296- 302.
Osborne, J.E., & Hutchinson, P.E. (2002). A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. British Journal of Plastic Surgery, 55(8), 611-615.
Pitman, G.H., Kopf, A.W., Bart, R.S., & Casson, P.R. (1979). Treatment of lentigo maligna and lentigo maligna melanoma. The Journal of Dermatologic Surgery and Oncology, 5(9), 727-737.
Popescu, N.A., Beard, C.M., Treacy, P.J., Winkelmann, R.K., O'Brien, P.C., & Kurland, L.T. (1990). Cutaneous malignant melanoma in Rochester, Minnesota: Trends in incidence and survivorship, 1950 through 1985. Mayo Clinic Proceedings, 65(10), 1293-1302.
Rivers, J.K., & McCarthy, W.H. (1991). No effect of topical tretinoin on lentigo maligna. Archives of Dermatology, 127(1), 129.
Robinson, J.K. (1994). Margin control for lentigo maligna. Journal of the American Academy of Dermatology, 31(1), 79-85.
Ryan, R.F., Krementz, E.T., & Litwin, M.S. (1988). A role for topical 5-fluorouracil therapy in melanoma. Journal of Surgical Oncology, 38(4), 250-256.
Schmid-Wendtner, M.H., Brunner, B., Konz, B., Kaudewitz, P., Wendtner, C.M., Peter, R.U., Plewig, G., & Volkenandt, M. (2000). Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. Journal of the American Academy of Dermatology, 43(3), 477-482.
Sober, A.J., Chuang, T.Y., Duvic, M., Farmer, E.R., Grichnik, J.M., Halpern, A.C., et al. (2001). Guidelines of care for primary cutaneous melanoma. Journal of the American Academy of Dermatology, 45(4), 579-586.
Thissen, M., & Westerhof, W. (1997). Lentigo maligna treated with ruby laser. Acta Dermato-Venereologica, 77(2), 163.
Urist, M.M., Balch, C.M., Soong, S., Shaw, H.M., Milton, G.W., & Maddox, W.A. (1985). The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer, 55(6), 1398-1402.
Veronesi, U., Cascinelli, N., Morabito, A., Bufalino, R., van der Esch, E.P., Preda, F., et al. (1980a). Prognosis of stage I melanoma of the skin. International Journal of Cancer, 26, 733-739.
Veronesi, U., Cascinelli, N., van der Esch, E.P., Breslow, A., Morabito, A., Bufalino, R., et al. (1980b). Stage I melanoma of the skin: The problem of resection margins. European Journal of Cancer, 16(8), 1079-1085.
Weinstock, M.A., & Sober, A.J. (1987). The risk of progression of lentigo maligna to lentigo maligna melanoma. British Journal of Dermatology, 116(3), 303-310.
Zalaudek, I., Horn, M., Richtig, E., Hodl, S., Kerl, H., & Smolle, J. (2003). Local recurrence in melanoma in situ: Influence of sex, age, site of involvement and therapeutic modalities. British Journal of Dermatology, 148(4), 703-708.
Zalla, M.J., Lim, K.K., DiCaudo, D.J., & Gagnot, M.M. (2000). Mohs micrographic excision of melanoma using immunostains. Dermatologic Surgery, 26(8), 771-784.
Zitelli, J.A., Brown, C.D., & Hanusa, B.H. (1997). Surgical margins for excision of primary cutaneous melanoma. Journal of the American Academy of Dermatology, 37(3 Pt 1), 422-429.
Zitelli, J.A., Moy, R.L., & Abell, E. (1991). The reliability of frozen sections in the evaluation of surgical margins for melanoma. Journal of the American Academy of Dermatology, 24(1), 102-106.